Invention Grant
- Patent Title: Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation
- Patent Title (中): 用于治疗异常细胞增殖和炎症疾病的代谢惰性抗叶酸剂
-
Application No.: US11223433Application Date: 2005-09-08
-
Publication No.: US07829708B2Publication Date: 2010-11-09
- Inventor: Michael J. Roberts , Simon Pedder
- Applicant: Michael J. Roberts , Simon Pedder
- Applicant Address: US NC Charlotte
- Assignee: Chelsea Therapeutics, Inc.
- Current Assignee: Chelsea Therapeutics, Inc.
- Current Assignee Address: US NC Charlotte
- Agency: Womble Carlyle Sandridge & Rice, PLLC
- Main IPC: C07D239/72
- IPC: C07D239/72 ; A61K31/519
Abstract:
The present invention provides compositions and methods for the treatment of disorders of abnormal cell proliferation and/or inflammation, such as psoriasis and inflammatory bowel disease, in a human or other host animals.
Public/Granted literature
Information query
